Eiger BioPharmaceuticals Investors

Eiger BioPharmaceuticals is a venture capital fund based in San Carlos, California, founded in 2008 The firm specializes in investing in innovative biopharmaceutical companies focused on addressing unmet medical needs Eiger BioPharmaceuticals typically engages in significant investment scales, providing substantial capital to support the development of transformative therapies The firms strategic approach emphasizes collaboration with portfolio companies to enhance value and drive growth in the biopharmaceutical sector

Estimated Revenue: $1M to $10M
Funding Status: IPO
Investor Type: Venture Capital Funds
Employee Number: 11-50
Industry: FemTech
Headquarters: USA
Founded Date: 2008
Technology: Neurological Disorders